The transcriptional response of Caenorhabditis elegans to ivermectin exposure identifies novel genes involved in the response to reduced food intake by Laing, S.T. et al.
Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk 
 
 
 
 
 
 
 
Laing, S.T., Ivens, A., Butler, V. , Ravikumar, S.P., Laing, R. , Woods, 
D.J., and Gilleard, J.S. (2012) The transcriptional response of 
Caenorhabditis elegans to ivermectin exposure identifies novel genes 
involved in the response to reduced food intake. PLoS ONE, 7 (2). 
e31367. ISSN 1932-6203 (doi:10.1371/journal.pone.0031367) 
 
 
http://eprints.gla.ac.uk/65483/ 
 
 
Deposited on: 15th June 2012 
 
 
The Transcriptional Response of Caenorhabditis elegans
to Ivermectin Exposure Identifies Novel Genes Involved
in the Response to Reduced Food Intake
Steven T. Laing1, Al Ivens2, Victoria Butler3, Sai P. Ravikumar3, Roz Laing1, Debra J. Woods4, John S.
Gilleard3*
1 Faculty of Veterinary Medicine, University of Glasgow, Glasgow, Strathclyde, United Kingdom, 2 Fios Genomics Ltd, The Edinburgh Technology Transfer Centre,
Edinburgh, Lothian, United Kingdom, 3 Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada, 4 Research and Development, Pfizer Animal Health,
Kalamazoo, Michigan, United States of America
Abstract
We have examined the transcriptional response of Caenorhabditis elegans following exposure to the anthelmintic drug
ivermectin (IVM) using whole genome microarrays and real-time QPCR. Our original aim was to identify candidate molecules
involved in IVM metabolism and/or excretion. For this reason the IVM tolerant strain, DA1316, was used to minimise
transcriptomic changes related to the phenotype of drug exposure. However, unlike equivalent work with benzimidazole
drugs, very few of the induced genes were members of xenobiotic metabolising enzyme families. Instead, the
transcriptional response was dominated by genes associated with fat mobilization and fatty acid metabolism including
catalase, esterase, and fatty acid CoA synthetase genes. This is consistent with the reduction in pharyngeal pumping, and
consequential reduction in food intake, upon exposure of DA1316 worms to IVM. Genes with the highest fold change in
response to IVM exposure, cyp-37B1, mtl-1 and scl-2, were comparably up-regulated in response to short–term food
withdrawal (4 hr) independent of IVM exposure, and GFP reporter constructs confirm their expression in tissues associated
with fat storage (intestine and hypodermis). These experiments have serendipitously identified novel genes involved in an
early response of C. elegans to reduced food intake and may provide insight into similar processes in higher organisms.
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Introduction
The macrocyclic lactone ivermectin (IVM) is one of the most
important drugs used for the control of animal and human
parasites [1,2]. It has been the mainstay of livestock parasite
control since the early 1980s, but intensive use has led to the
widespread development of drug resistance [2–5]. Over the last
decade IVM has been increasingly used in community-wide
treatment programs, aimed at the eradication of a number of
human filarial parasite species. Resistance appears now to be
emerging as a consequence of this intensive drug selection pressure
[6–8]. In order to maintain IVM efficacy in regions where
resistance has not arisen, and to aid in the development of novel
synergists, it is essential that the mechanism of action of the drug
and the molecular mechanisms employed by parasites that result
in resistance are elucidated.
Genetic, molecular and electrophysiological studies on the free-
living nematode Caenorhabditis elegans have been central to
identifying the major direct molecular targets of IVM [9–13]. It
acts by irreversibly binding to, and activating, ligand-gated ion
channels, particularly glutamate-gated chloride channels (GluCls),
resulting in paralysis of the body wall and pharyngeal muscles [14–
16]. This in turn leads to generalized paralysis and decreased
feeding. A number of comparative studies suggest that IVM acts in
a similar way in parasitic nematodes [15–17].
The ultimate effect of a drug on an organism is a balance
between the immediate effects of drug-receptor interaction;
secondary and compensatory responses to these interactions
(pharmacodynamics); and the effect of the organism on the drug
(pharmacokinetics). As discussed above, the immediate effect of
IVM-receptor interaction has been studied intensively, and is
known to cause pharyngeal and body wall paralysis. However, the
biological response of the nematode to this phenotype, and
potential compensatory mechanisms induced following drug
exposure, have received little attention. We have previously shown
that exposure of C. elegans to the benzimidazole drug albendazole
induces an array of xenobiotic metabolizing enzymes [18]. The
transcriptomic response of nematodes to IVM exposure, a highly
lipophilic drug that undergoes minimal metabolism in mammals,
has not previously been described [19].
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Wild-type C. elegans exposed to even low doses of ivermectin are
rapidly paralysed leading to death. In order to minimise non-
specific, stress-related changes in the transcriptome following drug
exposure, we made use of the strain DA1316, which has a null
mutation in three subunits of the glutamate-gated chloride channel
target of IVM. Although this strain is largely resistant to the
paralytic effects of IVM on the body wall, we found that following
four hours exposure to high doses of the drug there is a significant
decrease in pharyngeal function. As a result many of the
differences in gene expression noted between the IVM exposed
and unexposed groups are due to chemically induced reduced food
intake of the exposed nematodes.
As well as being accepted as a model for many features of
parasitic nematode biology, C. elegans is increasingly used as a
model for the basic biology of satiety and obesity [20,21]. There
have been many studies investigating the transcriptomic response
of C. elegans to starvation, in particular that of the long-lived,
anorexic dauer stage [22,23]. However, thus far investigation of
short-term food deprivation has been limited to real-time PCR
based studies of genes expected to be involved in this response
[24]. To the authors’ knowledge this is the first unbiased, whole-
genome investigation of the immediate effects of food deprivation
in C. elegans and in any whole organism.
Materials and Methods
C. elegans strains and maintenance
Strain DA1316 (avr-14(ad1302); avr-15(vu227); glc-1(pk54)) was
used in all experiments. This strain is a triple mutant of the
glutamate-gated chloride channel subunits avr-14, avr-15 and glc-1,
conferring high-level resistance to IVM (pers. Comm., Dr. J. Dent).
The wild-type strain used in pharyngeal pumping assays was the
Bristol N2 strain. Both strains were gifts from the Caenorhabditis
Genetics Center (CGC).
Synchronisation of cultures
Embryos were isolated by hypochlorite treatment of gravid
adults [25]. The embryos were transferred to a 5 cm diameter
Petri dish in 6 ml of S-buffer (129 ml/L 0.05 M K2HPO4,
871 ml/L 0.05 M KH2PO4, 0.1 M NaCl; pH 6.0), and main-
tained at 20uC overnight. The concentration of L1 larvae was
calculated the following day and experimental cultures initiated
immediately.
Pharyngeal pumping assay
IVM (Sigma, Gillingham, Dorset, UK) plates were prepared to
final concentrations of 0, 1, 10, 100 and 1000 ng/ml (0, 1.1 nM,
11.4 nM, 0.1 mM, 1.1 mM) IVM. Dimethyl sulphoxide (DMSO)
was used to dissolve the IVM and was present in all plates at a final
concentration of 0.01% v/v. Synchronised N2 and DA1316 L1
larvae were allowed to grow on standard nematode growth
medium (NGM) plates at 20uC for 53 hr. The L4/young adults
were then picked on to drug plates and allowed to remain at 20uC
for a further 4 hr. The number of pharyngeal pumps was counted
over a period of 1 min for five worms of each strain at each
concentration of drug.
Anthelmintic exposures
Ten thousand DA1316 L1 larvae per experimental condition
were grown for 53 hr at 20uC on standard NGM plates with OP50
bacterial lawns. The nematodes were assessed for comparable
staging between groups then washed from the plates with M9
buffer into a 50 ml falcon tube and washed twice in M9 buffer.
The suspension of worms was split equally between control plates
(DMSO 0.001% and 0.01% v/v for 100 ng/ml (0.1 mM) and
1 mg/ml (1.1 mM) IVM experiments respectively) and plates
containing 100 ng/ml (0.1 mM) or 1 mg/ml (1.1 mM) IVM (Sigma,
Gillingham, Dorset, UK) at a density of 500–600 worms per 5 cm
diameter plate. Drug and control plates were made and seeded
with 100 ml OP50 suspension 16–24 hr prior to the introduction of
the larvae. After 4 hr exposure the nematodes were washed from
the drug plates with M9 buffer, washed twice in M9 and the pellet
of worms snap frozen and stored in liquid nitrogen until RNA
extraction.
Real-time QPCR biological replicates
Separate biological replicates were carried out for analysis by
real-time QPCR (RTPCR) in an identical manner to the
microarray experiments except for the use of a commercial
preparation of IVM (Virbamec 5 mg/ml IVM, Virbac, Bury St.
Edmunds, Suffolk, UK). In order to compare the transcriptomic
response to IVM exposure and short-term food deprivation,
nematodes were first grown as per the acute drug exposure
protocol and then transferred either to plates containing IVM,
control plates or control plates with no OP50 food source for 4 hr
before harvesting. Investigation of gene up-regulation following
exposure to a gradient of IVM concentrations was undertaken.
Five matched cultures of C. elegans were grown in standard liquid
culture medium for 70 hr at 20uC, 200 rpm. Cultures were
exposed to 0, 1, 10, 100, 1000 ng/ml (0, 1.1 nM, 11.4 nM,
0.1 mM, 1.1 mM) IVM for 4 hr, harvested by sucrose flotation and
snap frozen in liquid nitrogen [26].
RNA methods
RNA extractions were carried out using Trizol Reagent
(Invitrogen, Paisley, UK), according to the manufacturer’s
instructions. Harvested C. elegans were homogenised in four
volumes Trizol reagent, subject to two chloroform extractions
and precipitated in isopropanol. The RNA was then treated with
RNase-free DNase I (Qiagen, Crawley, West Sussex, UK) in
solution before purification and concentration using RNeasy
columns (Qiagen, Crawley, West Sussex, UK). Quality and
concentration of RNA was assessed using an Agilent Bioanalyser
2100. Total RNA destined for microarray analysis was re-
precipitated in ethanol. RNA for real-time QPCR analysis was
reverse transcribed using a cloned AMV first strand synthesis kit
(Invitrogen, Paisley, UK) and random hexamer primers. 5 mg total
RNA for each sample was used as template and an identical
reaction lacking reverse transcriptase enzyme was carried out
simultaneously as a negative control. cDNA was purified using
PCR purification columns (Qiagen, Crawley, West Sussex, UK),
resuspended in 30 ml TE buffer and stored at 280uC until use.
Microarray hybridisation and analysis
Sample labelling and hybridisation to C. elegans whole genome
Genechips (Affymetrix, High Wycombe, UK) were performed
using standard Affymetrix protocols (http://media.affymetrix.
com/support/downloads/manuals/expression_analysis_techni-
cal_manual.pdf). These chips contain oligonucleotide probesets
designed to assess over 22500 transcripts from the C. elegans
genome. An updated annotation dataset was assembled for the C.
elegans probesets present on the Genechip. Data were sourced from
WormBase (Sept. 2008). Scanned array images (CEL files) were
quality control assessed using the arrayQualityMetrics Biocon-
ductor package (www.bioconductor.org) in the R environment
(www.r-project.org). Arrays identified as possible outliers were
removed from subsequent analyses. Linear model fitting of the
array data was undertaken, taking into account biological
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replicates using the limma (Linear Models for Microarray Data)
Bioconductor package (www.bioconductor.org/packages/bioc/
html/limma.html). The Rank Products algorithm was used to
assess differential expression of genes between test and control
groups and to assign significance to these changes [27].
Assignment of significance was carried out using a False Discovery
Rate (FDR) cut-off of 5–10%.
Gene Ontology analysis
DAVID software (the Database for Annotation, Visualisation
and Integrated Discovery) from the National Institutes of Health
was used to assess the functional annotation and clustering of the
differentially expressed genes [28,29]. Input into the program
consisted of probesets shown to be significantly altered in
expression using the Rank Products algorithm, with a false
discovery rate (FDR) of less than 10%. Prevalence of annotation
terms within the list of differentially expressed genes was compared
to the prevalence in the whole C. elegans genome. Fold enrichment
was calculated and a modified Fishers exact test (EASE score) used
to assign significance. Gene functional classification clustering was
carried out using medium stringency (DAVID).
Real-time Quantitative PCR
Relative quantitation of genes of interest was assessed using
Brilliant SYBR Green QPCR master mix (Agilent [Stratagene],
Stockport, Cheshire, UK) and a Stratagene Mx 300P QPCR
system with Stratagene MxPro software. ama-1, encoding a subunit
of RNA polymerase II, was used as a normalising gene. This
constitutively expressed gene showed no significant changes on
microarray analysis and has been extensively used as a normalising
gene in differential expression studies in C. elegans [30]. Gene
specific primers were designed to produce a product between 160
and 200 bp in length. The sequences of these primers can be
found in Table S1. The final concentration of primers was
between 300 nM and 400 nM in a total reaction volume of 25 ml.
Expression pattern analysis
GFP reporter constructs for mtl-1, scl-2, C23G10.11, cyp-37B1,
and ilys-3 were created using a PCR fusion protocol [31]. The
putative promoter region, 3 Kb upstream from the ATG start site
of the gene of interest, was fused to the gfp gene, including
synthetic introns and unc-54 39 UTR, from Fire vector pPD95.67
[32]. The plasmid used contained a gfp gene with a nuclear
localisation signal. Primer sequences can be found in Table S1.
Transgenic lines were created using the method of Mello et al.,
with the plasmid pRF-4 as a co-transformation marker to identify
transgenic worms [33]. Expression patterns were visualised using a
Zeiss, Axioscop 2 plus microscope. Images were collected and
processed using Improvision Openlab software (www.improvision.
com).
Results
Pharyngeal pumping rate of DA1316 is reduced
following exposure to IVM
Strain DA1316 is highly resistant to the effects of IVM on
motility. Although wild-type worms (N2) exposed to 100 ng/ml
(0.1 mM) IVM for as little as one hour exhibited a dramatic
paralysis phenotype, exposure of strain DA1316 to the same
concentration of drug for up to 6 hr had no visible effect on
motility, as has been previously described (data not shown). In
contrast, although the strain is resistant to the effects of IVM on
the pharynx relative to wild type worms, we found that four hours
exposure of DA1316 to IVM results in a significant decrease in
pharyngeal activity (Figure 1). The number of pharyngeal pumps
per minute is reduced by 50% following exposure to 100 ng/ml
(0.1 mM) IVM. The drug is thought to elicit its effect on the
pharynx via the AVR-15 subunit in pharyngeal GluCls [9,12].
However, avr-15 (vu227), presumed to be a null mutation of avr-15,
does not appear to confer complete resistance to the effect of IVM
on the C. elegans pharynx.
Acute exposure of DA1316 to 0.1 mM and 1.1 mM IVM
results in differential expression of a distinct set of genes
that may be involved in the response to food deprivation
Microarray analysis was performed on RNA from five biological
replicates of strain DA1316 exposed to 100 ng/ml (0.1 mM) IVM.
Twelve probesets were considered to be significantly up-regulated
and three considered to be significantly down-regulated
(FDR,5%). The top 10 up-regulated genes, based on log2 fold
change, are listed in Table 1. Many of the up-regulated genes are
uncharacterised, but those with known or putative functions may
have roles in fat metabolism. Given the low number of genes
showing significant changes in expression the experiment was
repeated using 1 mg/ml (1.1 mM) IVM in a similar manner. Again
five drug-exposed and five matched controls underwent analysis.
The rank products algorithm revealed 369 probesets to be
significantly altered in expression with a FDR correction to 5%
(216 up-regulated and 153 down-regulated). Figure 2 summarises
the microarray data and Table 2 lists the top 10 up-regulated and
down-regulated probesets based on log2 fold change. Full
microarray data is available in Table S2 and online at the
GEO website, accession number GSE22660. Many genes are
represented in the top up-regulated and down regulated lists for
both the 0.1 mM and 1.1 mM experiments, including the presence
of mtl-1, scl-2 and cyp-37B1 in the top four up-regulated genes,
which suggests there is a consistent response at the two doses of
drug.
Genes that showed significant changes in expression level
following exposure of strain DA1316 to 1 mg/ml (1.1 mM) IVM
(FDR,10%) were subject to ontology analysis. A less stringent
FDR cut-off was used to widen the scope of the analysis and
included 254 up-regulated and 186 down-regulated genes. The
gene ontology terms associated with a minimum of two genes and
with an associated EASE score (p-value) of #0.1, for both data
sets, are described (Table S3 and S4). Only 72 up-regulated and
94 down-regulated genes were associated with significantly
enriched ontology terms. This is likely due to the large number
of completely uncharacterised genes in both sub-categories.
Up-regulated terms include oxidoreductase activity, generation of
precursor metabolites and energy; metabolic process; organic acid metabolic
process; carboxylic acid metabolic process and catabolic process. These
terms are associated with several genes which may be important in
fatty acid synthesis, breakdown and metabolism including five
cytochrome P450 genes, two flavin containing monooxygenases
(FMO) and three catalase genes; two short chain dehydrogenase
genes and an alcohol dehydrogenase gene; a fatty acid desaturase
gene and a gamma butyrobetaine hydroxylase (potentially
involved in carnitine biosynthesis). The most significantly enriched
biological process ontology term is aging, which includes mtl-1, sodh-
1, cyp-34A9 and dod-3. In addition, this group contains other down-
stream targets of DAF-16, the sole C. elegans forkhead Box O
transcription factor homologue and a mediator of insulin signalling
[21,34]. These include catalase genes (ctl-2, ctl-1); a gut esterase
(ges-1); a fatty acid CoA synthetase gene (acs-17); a predicted
isocitrate lyase/malate synthase (gei-7); and an acylsphingosine
amidohydrolase (asah-1). All of these genes may be involved in fatty
acid metabolism pathways. Furthermore, the only KEGG
IVM Exposure Up-Regulates Nutrient Response Genes
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pathway term to be significantly enriched in the up-regulated gene
list was fatty acid metabolism. This was associated with five genes:
F54F3.4, acs-2, sodh-1, acs-17 and F58F9.7.
The down-regulated gene-list is significantly enriched for the
biological process term carboxylic acid metabolic process, which is
associated with the fatty acid desaturase genes fat-5, fat-6 and fat-7;
and several hypothetical proteins with acyl-CoA thioesterase, acyl-
CoA dehydrogenase, acyl-CoA oxidase, glycine dehydrogenase
KOGs. Additionally, the fatty acid elongase genes elo-2, elo-5 and
elo-6; and genes involved in lipid transport, including the
vitellogenins vit-1, vit-3 and vit-4, are down-regulated. Carbohydrate
metabolic processes, exemplified by the UDP-glucuronosyl transfer-
ases ugt-12, ugt-46; the lysozyme genes lys-5 and lys-6; gale-1 (a
putative UDP-galactose-4-epimerase) and ger-1 (a putative GDP-
keto-6-deoxymannose 3,5-epimerase/4-reductase) are also en-
riched in the down-regulated gene list. Further evidence that
IVM exposure does not result in a classical xenobiotic response is
seen by the significant down-regulation of the molecular function
terms catalytic activity, oxidoreductase and transferase activity. These
terms are associated with six UDP-glucuronosyl/glucosyl trans-
ferases, four glutathione-s-transferases, one cytochrome P450 and
one short-chain dehydrogenase; all of which represent gene
families that would be expected to be up-regulated in a xenobiotic
detoxification response.
The transcriptomic response to IVM exposure is inconsistent
with a general stress response: A panel of genes that have been
associated with stress, such as hsp-70, gst-1, gst-38, sip-1 and HSF-1,
show no significant change in expression in the microarray
experiments; and others such as hsp-16.1, hsp-16.49 and gst-4 are in
fact significantly down-regulated in the current study (Table S5).
Instead, the overall analysis suggests that the predominant
response is associated with an increase in lipid catabolism. We
hypothesised that this was likely to be a result of short-term food
deprivation associated with the reduced pharyngeal pumping, and
hence feeding, which occurs following exposure of the DA1316
strain to IVM. In order to investigate this hypothesis further we
Figure 1. Pharyngeal pumping rate following 4 hr exposure of DA1316 and N2 to 0–1000 ng/ml (1.14 mM) IVM.Whilst strain DA1316 is
more resistant to IVM induced pharyngeal paralysis, at concentrations greater than 100 ng/ml (0.1 mM) the pharyngeal pumping rate is significantly
reduced. The pharyngeal pumping rates of five worms were counted at each concentration of IVM and the error bars represent the standard
deviation.
doi:10.1371/journal.pone.0031367.g001
Table 1. Top 10 up-regulated probesets based on fold change following 4 hr exposure of DA1316 to 100 ng/ml (0.1 mM) IVM.
Probeset Gene ID Log2 FC FDR Ontology
172744_at mtl-1 1.59 0 metallothionein
184913_s_at T22F3.11 1.44 0 permease of major facilitator family KOG
192737_at scl-2 1.31 0 sterol carrier-like protein
189221_at cyp-37B1 1.27 0 cytochrome P450 (CYP4/19/26 subfamilies)
186971_at C23G10.11 1.23 0 uncharacterised
173729_at T22F3.11 1.21 0 permease of major facilitator family KOG
183381_at C50F7.5 1.12 1.00E-02 uncharacterised
186521_at F21C10.10 1.10 1.11E-02 uncharacterised
173550_at F45D3.4 1.08 1.25E-02 uncharacterised
190978_at sodh-1 1.07 1.82E-02 alcohol dehydrogenase class V KOG
doi:10.1371/journal.pone.0031367.t001
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Table 2. Top 10 up-regulated and down-regulated genes based on fold change following 4 hr exposure of DA1316 to 1 mg/ml
(1.1 mM) IVM.
UP-REGULATED GENES
Probeset Gene ID Log2 FC FDR Ontology
172744_at mtl-1 4.99 0 metallothionein
192737_at scl-2 3.27 0 sterol carrier-like protein
186971_at C23G10.11 3.20 0 uncharacterised
189221_at cyp-37B1 3.09 0 cytochrome P450 (CYP4/19/26 subfamilies)
177613_at F57G8.7 3.01 0 uncharacterised
177671_at K03D3.2 2.83 0 uncharacterised
178900_s_at F45D3.4 2.77 0 uncharacterised
187964_at F54F3.3 2.51 0 triglyceride lipase-cholesterol esterase KOG
180946_at ilys-3 2.51 0 invertebrate lysozyme
173335_s_at dod-3 2.33 0 down stream of daf-16
DOWN-REGULATED GENES
176939_at spp-23 22.79 0 saposin-like protein family
190404_s_at folt-2 22.55 0 putative folate transporter
179187_s_at F46F2.3 22.36 0 uncharacterised
189345_at pho-13 21.88 0 predicted intestinal acid phosphatase
192528_at C35A5.3 21.83 0 uncharacterised
187085_s_at gst-10 21.77 0 glutathione-s-transferase
190744_at ugt-63 21.77 0 UDP-glucuronosyl/glucosyl transferase KOG
175489_at F18E3.11 21.72 0 uncharacterised
177747_at F58G6.9| srm-3 21.72 0 uncharacterised
188441_at F21F8.4 21.70 0 KOG- aspartyl protease
doi:10.1371/journal.pone.0031367.t002
Figure 2. Model fitted log2 control chip intensity vs. log2 IVM (1 mg/ml, 1.1 mM) chip intensity. The scatter plot represents the entire
22625 probesets represented on the Affymetrix chips. The upper and lower dashed lines represent up-regulation greater than 2-fold and down-
regulation greater than 2-fold respectively. The data points marked A-H represent the top 10 up-regulated genes in Table 2.
doi:10.1371/journal.pone.0031367.g002
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compared our data to that of Van Gilst (2005) who identified 18
genes whose expression was significantly influenced by food
withdrawal, using a quantitative real-time PCR screen of 97
candidate genes (Figure 3) [24]. The majority of the 18 genes
identified by Van Gilst et al. as fasting response genes were
similarly differentially expressed in microarray analysis of DA1316
exposed to IVM. This supports the hypothesis that the
predominant response to IVM was secondary to its effect on the
nematode pharynx. cpt-4 was the only gene whose regulation was
discordant, being up-regulated in response to IVM exposure and
down- regulated in response to fasting. However, this gene is
thought to encode a carnitine palmitoyl transferase, which would
be expected to be up-regulated with increased fat catabolism.
Real-time QPCR confirmation of microarray data
Genes which showed the greatest fold up-regulation following
IVM exposure in the microarray experiments were further assessed
using real- time QPCR. All of the genes examined that were
proposed to be up-regulated by the microarray experiments were
confirmed to be up-regulated by this technique (Figure 4). sip-1, gst-1
and HSF-1 are genes that have been associated general stress
responses. These were included in the RT-QPCR analysis as negative
controls and none showed any evidence of induction, supporting the
earlier conclusion of a lack of a generalised stress response to IVM
exposure. Expression of cyp-35C1, which we have shown to be up-
regulated in response to albendazole exposure, was unchanged
following IVM exposure [27]. In addition, pgp-1, an example of the p-
glycoproteins that have been advocated to be responsive to chronic
IVM exposure, showed no change in expression [35].
cyp-37B1, mtl-1 and scl-2 represent novel genes involved
in the response to food deprivation
cyp-37B1, mtl-1 and scl-2 were in the top four induced genes for
both the 100 ng/ml (0.1 mM) and 1 mg/ml (1.1 mM) microarray
experiments and their high level of induction was confirmed by
RT-PCR. Additionally, both cyp-37B1 and mtl-1 have previously
been shown to be responsive to exposure to other xenobiotics
including clofibrate, b-naphthoflavone, PCB52, fluoranthene,
progesterone and oestrogen [36–38]. Therefore, these genes were
examined in more detail to characterize their response to both
IVM exposure and food withdrawal.
First, the dose responsiveness of cyp-37B1, scl-2 and mtl-1 was
examined to relate the effects to those seen on the pharyngeal
paralysis phenotype (Figure 5A). All respond to IVM in a dose
responsive manner, with significant changes occurring in gene
expression at doses of IVM greater than 10 ng/ml (11.4 nM). This
is consistent with the drug concentration at which IVM begins to
affect the pharynx of DA1316 (Figure 1). The induction of
expression of these three genes following nutritional deprivation
(food removal) for 4 hr was examined and all were found to be up-
regulated (Figure 5B). Furthermore, the level of induction was
very similar to that produced by a 4 hr exposure to 1 mg/ml
(1.1 mM) of IVM, a concentration that results in almost complete
pharyngeal paralysis in DA1316. cyp-35C1, included as a negative
Figure 3. Differential expression of 18 fasting response genes*, in the 1 mg/ml (1.1 mM) IVM exposure microarray experiment. In
general genes that were shown to be induced by fasting were also induced following exposure to IVM and fasting repressed genes were also
repressed by IVM exposure. *Taken from van Gilst et al. 2005 [24].
doi:10.1371/journal.pone.0031367.g003
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control, shows no change in either of the conditions examined in
the current study.
IVM responsive genes are predominantly expressed in
the intestine and hypodermis
The expression patterns of a number of the induced genes were
investigated. GFP transgenes of mtl-1, cyp-37B1 and scl-2 and ilys-3
showed GFP expression in the intestinal cells (Figure 6), which is
an important site for fat storage [39]. Additionally, mtl-1 showed
expression in the terminal bulb of the pharynx (Figure 6), as has
been reported previously [39,41]. In addition to the intestinal cells,
the transcriptional reporter for cyp-37B1 showed expression in two
cells in the tail region, which were assumed to be the phasmid
neurons. These are proposed to be chemosensory neurons
involved in avoidance of noxious chemical stimuli [42].
C23G10.11 was expressed in the hypodermal cells, which are
also proposed to be a site of fat storage [43].
Discussion
The transcriptional response of C. elegans strain DA1316
exposed to IVM is dominated by genes associated with
fat mobilization and fatty acid metabolism
The transcriptional response of the C. elegans strain DA1316 (avr-
14(ad1302); avr-15(vu227); glc-1(pk54)) to IVM appears to be
dominated by genes associated with the consequences of food
deprivation, such as changes to fatty acid metabolism, many of
which are conserved in higher mammals. Comparative analysis of
our results with those of Van Gilst et al. (2005), provide compelling
evidence for this (Figure 3) [24]. Furthermore we have directly
demonstrated that the three genes most consistently induced by
IVM exposure in our experiments (mtl-1, cyp-37B1 and scl-2) are in
fact directly inducible by food withdrawal in the absence of the
drug. This conclusion is supported by the phenotype of the
DA1316 strain when exposed to IVM. Although this strain, which
has null mutations in three glutamate-gate chloride channels (avr-
14, avr-15 and glc-1), is highly resistant to the paralytic effects of the
drug on body wall muscle, we found it was still sensitive (albeit less
than wild type) to IVM induced pharyngeal paralysis (Figure 1).
At doses of IVM of 100 ng/ml (0.1 mM) reduced pharyngeal
pumping was evident with almost complete paralysis at 1 mg/ml
(1.1 mM) (Figure 1). Hence the major effect of IVM on the
DA1316 worms is likely to be a reduction in food intake. It should
be noted that, in contrast, Ardelli et al. (2009) reported that an avr-
14, avr-15 and glc-1 triple mutant showed no reduction in
pharyngeal activity following 2.5 hr exposure to IVM at
concentrations of up to 5 mM [44]. It may be that the longer
period of exposure, 4 hr in the current study compared to 2.5 hr
in that of Ardelli et al., explains these differences.
We did not specifically investigate the effects of IVM-induced
reduction of pharyngeal pumping rate on worm development and
growth. However, it is interesting to note that DA1316 larvae
grown on NGM containing IVM took longer to reach adulthood
compared with those grown on drug-free plates; even at IVM
doses as low as 11.4 nM (data not shown). At present, the extent to
which the transcriptional response described here leads to
metabolic changes that functionally compensate for reduced feed
intake is not clear, and this will be an interesting area of future
investigation.
These results also provide an interesting example of the care
that needs to be taken when interpreting the transcriptional
responses to drug exposure. At first sight some of the induced
genes could be interpreted as being part of a specific xenobiotic
response to IVM exposure, and perhaps represent candidate
enzymes that may metabolize the drug. The cytochrome P450
gene cyp-37B1 might be taken to be such a candidate. However,
cytochromes P450 have roles in many constitutive biological
processes in addition to drug metabolism, and in this case our
results are more likely to implicate this enzyme in endogenous fatty
acid metabolism rather than xenobiotic metabolism.
Identification of novel genes induced in an early
response to food deprivation
C. elegans has been established in the literature as a model for the
investigation of fat metabolism and obesity [20,21]. Whilst there is
a huge amount of information regarding the medium and long
term effects of food withdrawal on C. elegans and the induction of
the dauer stage, little is known about the response of the worm to
Figure 4. RTPCR assessment of gene expression following 4 hr exposure to IVM. Strain DA1316 was exposed to 1 mg/ml [1.1 mM] IVM
(Virbamec) for 4 hr. Results are expressed as fold change relative to an unexposed control. Biological replicates were carried out in triplicate and the
error bars represent the standard error. All genes proposed to be up-regulated by microarray were confirmed by RT-QPCR.
doi:10.1371/journal.pone.0031367.g004
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the earliest effects of food withdrawal. The identification of genes
that are induced by short-term food deprivation was an
unanticipated result of this study that is nevertheless potentially
important. We have confirmed three of the genes (mtl-1, cyp-37B1
and scl-2) induced by IVM exposure are truly induced by food
withdrawal. Many of the other induced genes, most of which have
not been ascribed a functional annotation, are likely to also be
novel early fasting response/fat metabolism genes. An investiga-
tion of this and their role in these processes will be an interesting
area of future study and may be relevant to fat mobilization and
the molecular response to food deprivation in mammals.
mtl-1, cyp-37B1 and scl-2 have not been previously implicated in
fasting responses or fat metabolism in C. elegans and so it is
interesting to speculate on their roles in these processes. mtl-1 is a
metallothionein gene, which is inducible in response to heavy
metal intoxication and stress adaptation [40]. Both rat and mouse
mtl genes have been shown to be induced following fasting and
may act as an antioxidant in the mouse [45–47]. However,
metallothioneins have also been proposed to be involved in zinc
signalling pathways within mammalian cells [48]. The C. elegans
mtl-1 gene is significantly divergent from the mammalian genes. In
fact, Ce-mtl-1 is the largest known metallothionein gene thus far
investigated and therefore the function of MTL-1 may also be
divergent in this species [40]. Interestingly, mtl-1 has been noted to
be up-regulated in response to several xenobiotics including
progesterone, clofibrate and b-naphthoflavone and was also up-
Figure 5. Up-regulation of cyp-37B1, mtl-1 and scl-2 in response to varying concentrations of IVM and fasting. A. Up-regulation of the
genes of interest appears to occur in a dose-dependent manner. Biological replicates were carried out in duplicate and the error bars represent the
standard error. B. There are no significant differences in the fold up-regulation of the genes investigated following exposure to 1 mg/ml (1.1 mM) IVM
and 4 hr fasting. cyp-35C1 (a gene transcriptionally induced by benzimidazole drug exposure [18]), included as a control, was unaffected by either
treatment.
doi:10.1371/journal.pone.0031367.g005
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regulated in nematodes grown in axenic culture [36,38,49]. The
phenotype of worms exposed to these xenobiotics was not reported
in the literature. However, it seems likely that induction of mtl-1
occurs under many different circumstances and may represent
part of a common signalling pathway rather than an effector
protein in the response to xenobiotic intoxication or food
withdrawal.
The mtl-1 transcriptional GFP reporter construct showed
constitutive expression in the intestine. Previous reported studies
have suggested that whilst mtl-1 can be induced in the gut,
constitutive expression is only found in the posterior bulb of the
pharynx [41]. This would also suggest that mtl-1 expression is
higher in strain DA1316 than wild-type worms. The reason for
this may be due to a level of pharyngeal dysfunction noted in
glutamate-gated chloride channel subunit mutants, also noted in
the slightly lower resting pharyngeal pumping rate of this strain
(Figure 1) [10]. Hypothetically, this could result in slightly
decreased food intake and a chronic up-regulation of the pathways
involved in this response.
There have been no citations for scl-2 in the literature and its
function remains largely unknown. However, the gene encodes a
sterol carrier-like protein domain and may potentially be involved
in the transport of steroid hormones or lipid breakdown products.
Up-regulation of a gene involved in such processes during food
deprivation would be expected. Expression of scl-2 appears to be
confined to the intestinal cells at all stages. The intestinal cells
represent a major site of fat storage in the nematodes [39].
Therefore, the localised expression of scl-2 in the intestine makes it
ideally placed for involvement in fat mobilization.
cyp-37B1 represents a cytochrome P450 gene which encodes a
CYP4/CYP19/CYP26 domain. Again, this gene has been shown
to be up-regulated in response to other xenobiotics, but the
phenotype of the exposed worms was not reported [36–38].
BLASTp analysis reveals that isoform 1 of CYP4V2 is a
homologue of C. elegans CYP37B1 in the Homo sapiens genome
(BLAST E-value 7.9610298, 90.6% length). Mutations of the gene
encoding CYP4V2 have been associated with Bietti Crystalline
Corneoretinal Dystrophy and the protein has recently been
characterised as a fatty acid {omega}-hydroxylase [50,51]. cyp-
37B1(RNAi) suggests that this gene may have limited hydroxylase
activity against eicosapentaenoic acid in C. elegans [52]. Therefore,
it is possible that this cytochrome P450 is also involved in fat
mobilisation in response to food deprivation. The expression of
this gene in the intestine of the nematodes corroborates this
hypothesis. However, there was also expression in the phasmid
neurons, which may suggest involvement in chemosensation.
Certainly, C. elegans appear to be able to sense IVM in their
environment. Both wild-type (N2) and DA1316 animals will
attempt to migrate off IVM containing NGM plates at
concentrations of drug not high enough to cause immediate
paralysis (data not shown).
Our initial hypothesis, that exposure of C. elegans to IVM would
result in the up-regulation of xenobiotic metabolising enzymes, has
been largely disproved in the current study. However, the
pharyngeal dysfunction and associated decreased food intake
caused by IVM, even in a highly resistant strain such as DA1316,
has resulted in the identification of genes not previously implicated
in food deprivation. Further investigation into the function of these
Figure 6. GFP expression patterns of IVM responsive genes. mtl-1, scl-2, cyp-37B1 and ilys-3 are expressed in the intestine and C23G10.11 is
expressed in the hypodermal cells. These are both proposed sites of fat storage.
doi:10.1371/journal.pone.0031367.g006
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genes should provide insight into the molecular pathways involved
in reduced food intake, fasting and fat mobilization, both in
nematodes and in higher species. Additionally, the recognition that
IVM still induces a degree of pharyngeal paralysis in a mutant
carrying null mutations in three glutamate-gated chloride channel
subunits (avr-14, avr-15 and glc-1) suggests the existence of
additional targets of the drug that are involved in nematode
pharyngeal function.
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